tradingkey.logo
搜索

DaVita Inc

DVA
添加自选
210.975USD
+1.295+0.62%
收盘 06/23, 16:00美东报价延迟15分钟
13.96B总市值
19.29市盈率 TTM

关于 DaVita Inc 公司

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Inc简介

公司代码DVA
公司名称DaVita Inc
上市日期Oct 31, 1995
CEORodriguez (Javier J)
员工数量76000
证券类型Ordinary Share
年结日Oct 31
公司地址2000 16th St
城市DENVER
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编80202-5117
电话13105362668
网址https://www.davita.com/
公司代码DVA
上市日期Oct 31, 1995
CEORodriguez (Javier J)

DaVita Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
15.53K
-101.43%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
14.02K
+1.78%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
9.53K
-50.27%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.81K
+3.20%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%

常见问题

DaVita Inc的前五大股东是谁?

DaVita Inc 的前五大股东如下:Mr. Javier J. Rodriguez

有多少机构持有DaVita Inc(DVA)的股份?

截至2026Q1,共有1310家机构持有DaVita Inc的股份,合计持有的股份价值约为36.02M,占公司总股份的56.10%。与2025Q4相比,机构持股有所增加,增幅为-3261619.00。

哪个业务部门对DaVita Inc的收入贡献最大?

在2026Q1,Patient service - Medicare and Medicare Advantage业务部门对DaVita Inc的收入贡献最大,创收6.74B,占总收入的49.41%。
KeyAI